ArticleTranslational oncology2020

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma.

Coralie Reger de Moura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.